Frazier Financial Advisors’s Puma Biotechnology PBYI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$924 Buy
+93
New +$818 ﹤0.01% 659
2026
Q2
– Sell
-183
Closed -$1.17K – 787
2026
Q1
$1.17K Buy
+183
New +$1.18K ﹤0.01% 607

Other funds holding PBYI

Frazier Financial Advisors's PBYI Position: Q3 2026 in Review

Frazier Financial Advisors opened a new position in Puma Biotechnology (PBYI) in Q3 2026: 93 shares worth $924. The stake represents ﹤0.01% of the portfolio and ranks #659 among its holdings. This is a return to the name: Frazier Financial Advisors previously reported a position in PBYI as recently as Q1 2026.

Frazier Financial Advisors first reported a position in PBYI in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.17K in Q1 2026. 156 funds tracked by Wall St. Rank hold PBYI as of Q3 2026.

  • Frazier Financial Advisors held 93 shares of Puma Biotechnology worth $924 as of Q3 2026.
  • Puma Biotechnology was a new Frazier Financial Advisors position in Q3 2026.
  • Puma Biotechnology made up ﹤0.01% of Frazier Financial Advisors's portfolio in Q3 2026, its #659 holding.
  • Frazier Financial Advisors first reported a position in Puma Biotechnology in Q1 2026 and has held it in 2 quarters since.
  • Frazier Financial Advisors's Puma Biotechnology position peaked at $1.17K in Q1 2026.
  • 156 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2026.

Based on Frazier Financial Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.